- Home
- INBS vs CARM Comparison
INBS vs CARM Comparison
Compare INBS & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBS
- CARM
- Stock Information
- Founded
- INBS 2016
- CARM 2016
- Country
- INBS United States
- CARM United States
- Employees
- INBS N/A
- CARM N/A
- Industry
- INBS Medical Specialities
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- INBS Health Care
- CARM Health Care
- Exchange
- INBS Nasdaq
- CARM Nasdaq
- Market Cap
- INBS 11.7M
- CARM 12.2M
- IPO Year
- INBS N/A
- CARM N/A
- Fundamental
- Price
- INBS $1.65
- CARM $0.40
- Analyst Decision
- INBS
- CARM Hold
- Analyst Count
- INBS 0
- CARM 5
- Target Price
- INBS N/A
- CARM $0.90
- AVG Volume (30 Days)
- INBS 106.6K
- CARM 25.4M
- Earning Date
- INBS 11-06-2025
- CARM 11-06-2025
- Dividend Yield
- INBS N/A
- CARM N/A
- EPS Growth
- INBS N/A
- CARM N/A
- EPS
- INBS N/A
- CARM N/A
- Revenue
- INBS $3,052,532.00
- CARM $10,767,000.00
- Revenue This Year
- INBS $778.48
- CARM N/A
- Revenue Next Year
- INBS N/A
- CARM N/A
- P/E Ratio
- INBS N/A
- CARM N/A
- Revenue Growth
- INBS N/A
- CARM N/A
- 52 Week Low
- INBS $1.10
- CARM $0.14
- 52 Week High
- INBS $3.00
- CARM $1.27
- Technical
- Relative Strength Index (RSI)
- INBS 55.67
- CARM 59.74
- Support Level
- INBS $1.49
- CARM $0.30
- Resistance Level
- INBS $1.70
- CARM $0.56
- Average True Range (ATR)
- INBS 0.11
- CARM 0.05
- MACD
- INBS 0.02
- CARM 0.02
- Stochastic Oscillator
- INBS 84.31
- CARM 54.05
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.